Forian (FORA) Stock Price

Forian Price

NASDAQ·CLOSED
2.17
​
Market closed

Revenue has compounded at 25.3% per year over the past 20 years to 20.15 M USD. Forian's net margin stands at -18.7%, up from -922.2% several years earlier. Analysts set a median price target of 2.14 USD, implying 1.3% below the current price. Of 6 analysts, 0 rate the stock a buy — an overall Sell consensus.

Forian stock price

Access this data via the Eulerpool API

Forian business model & stock analysis

Forian, Inc. engages in the provision of healthcare information, analytics and technology services. The company is headquartered in Newtown, Pennsylvania and currently employs 143 full-time employees. The company went IPO on 2021-03-03. The company provides a suite of data management capabilities and data and analytics to optimize and measure operational, clinical, and financial performance for customers within the traditional and emerging life sciences, healthcare payer and provider segments. Its segments include Information and Software, Services, and Other. The Information and Software segment licenses information and software products to customers. The Services segment provides implementation, support, and training on a contractual basis to customers. The Other segment consists of certain other business operations, primarily in security and marketing services. Its data management and data science solution organize, normalizes, standardize, integrate, enhance and publish consumable transactional information through access and delivery channel. Its patient registries solution provides understanding of disease progression, treatment protocol, and therapeutic effectiveness.

Frequently asked questions about Forian

Analysts currently set an average price target of 2.14 USD for the Forian stock (median: 2.14 USD), implying -1.3 % versus the latest price. The consensus is based on 6 analyst ratings.

6 analysts currently rate the Forian stock: 0 recommend buying, 3 holding and 3 selling. For 2026, analysts expect Forian to generate revenue of 32.81 M USD and earnings per share of 0.09 USD.

Converted at the current exchange rate, the Forian share trades at 1.93 EUR (2.17 USD).

The Forian share (FORA) is listed on 1 stock exchanges, including: NASDAQ (FORA).

The expected revenue of Forian is 32.81 M USD. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Forian is 2.85 M USD. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Forian is currently 23.64. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Forian stock.

The price-to-sales ratio (P/S) of Forian is currently 2.05. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Forian stock.

The Eulerpool Quality Score for Forian is 4/10.

The ISIN of Forian is US34630N1063. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Forian is FORA. The ticker symbol is used to trade Forian shares on the stock exchange.

Fair ValueTerminal
1.95 USD
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Technology
Number of shares
Employees
Revenue per Employee
140,932.17 USD
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website forian.com
Currency
USD
Initial public offering
Mar 3, 2021
ISIN
US34630N1063
Cusip
34630N106
Market capitalization
67.42 M USDMicro Cap
52-Week Range
Revenue growth (10Y) > 5%
Revenue growth (3Y) > 5 %
EBIT growth (10Y) > 5%
EBIT growth (3Y) > 5 %
Net debt < 4x EBIT
Profitable since 10Y+
EBIT Drawdown (10Y) < 50%
Return on Equity (ROE) > 15%
ROCE > 15%
Return Expectation > 10%
PEG
—
P/E ratio
P/Ee 2025
30.39
P/Ee 2026
23.64
P/S
P/Se
2.20
EV/EBIT
—
P/B Ratio
2.24
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-10.26 %
Gross Margin
63.61 %
EBIT Margin
-27.59 %
Net Margin
-18.71 %
EPS (Earnings Per Share)
-0.12 USD
Net Debt / EBIT
-0.38
Debt/Equity
0.22
Last updated Oct 3, 2026, 10:15 PM

Forian Peer Group

Forian Ticker

NASDAQ · FORA

Forian FIGI

FORA:US · BBG00Y9CR7V0FORA:UA · BBG00Y9DGR37FORA:UC · BBG00Y9DGR46FORA:UN · BBG00Y9DGR64FORA:UP · BBG00Y9DGR73FORA:UB · BBG00Y9DGR91FORA:UM · BBG00Y9DGRC7FORA:UX · BBG00Y9DGRD6FORA:UR · BBG00Y9DGRF4FORA:UD · BBG00Y9DGRK8FORA:UF · BBG00Y9DGRN5FORA:VY · BBG00Y9DGRP3

All fundamentals and in-depth analysis of Forian

Our stock analysis for Forian stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Forian. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.